← Open Payments lookup

LACIE HARRIS: Open Payments

NPI 1366918328 · LONGVIEW, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$221 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $28 · 2025 $221

Food & beverage: $221
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$66
Novo Nordisk Inc2$35
Lilly USA, LLC2$30
GlaxoSmithKline, LLC.1$29
IDORSIA PHARMACEUTICALS US INC1$23
ABBVIE INC.1$15
Corium, LLC1$12
Phathom Pharmaceuticals, Inc.1$11

Products named: FARXIGA, JARDIANCE, TRELEGY ELLIPTA, Quviviq, Ozempic, Wegovy, AIRSUPRA, QULIPTA.

Industry payments across TX — which companies pay providers there.